Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(17%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
17%
Ph not_applicable
3
50%
Ph phase_1
1
17%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(2)
Other(3)

Detailed Status

unknown3
Completed2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (20.0%)
Phase 31 (20.0%)
N/A3 (60.0%)

Trials by Status

unknown350%
recruiting117%
completed233%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DEVICE
Total Trials
6